Pennsylvania House Directed Study of PANDAS and PANS
State lawmakers approved a resolution to study PANDAS and PANS treatment coverage in Pennsylvania.
Updated on Sept. 22, 2026 in Autism
In the summer of 2026, the Pennsylvania state House passed a resolution directing the Joint State Government Commission to study PANDAS and PANS. This action aims to evaluate medical literature and state policies to inform future insurance coverage legislation.
Why it matters
The study follows advocacy from families like the Janedas, who were denied insurance coverage for their daughter's treatment. The commission will now evaluate how Pennsylvania can address gaps in coverage for these conditions.
PANDAS has an estimated prevalence of 1 in 200 children, while treatments such as IVIG can cost $11,000 monthly. The Joint State Government Commission is now tasked with a study spanning the next 18 months.
The players
Macy Janeda
She is a 10-year-old patient who developed symptoms of PANDAS after a strep throat infection.
Jill Cooper
She is a state representative for Westmoreland County who presented the resolution to the state House.
Joint State Government Commission
It is a bipartisan, bicameral research agency that conducts studies to assist the Pennsylvania General Assembly.
The details
State Representative Jill Cooper introduced the resolution after hearing from local families seeking legislative change. The commission will research clinical guidelines and state policies, aiming to provide legislative suggestions after completing their 18-month review.
Timeline
March 2026: Macy Janeda developed symptoms following a strep infection.
Summer 2026: Pennsylvania House passed the PANDAS study resolution.
Next 18 months: Joint State Government Commission performs the study.
Health Landscape
This resolution reflects a broader trend of state legislatures engaging with complex medical conditions that lack standardized insurance coverage. It marks a departure from current Pennsylvania policies that do not mandate coverage for PANDAS, potentially setting a precedent for future legislative action.
Families affected by PANDAS or PANS in Pennsylvania may see future legislative efforts aimed at lowering out-of-pocket costs for treatments like IVIG. Currently, the lack of a coverage mandate requires families to navigate insurance denials and seek out-of-network care.
The takeaway
Advocacy efforts in Pennsylvania highlight the financial strain faced by families managing rare or complex pediatric conditions. The upcoming commission study serves as a critical step toward identifying how state policy can bridge the gap between medical needs and insurance accessibility.
Further reading
Learn more about the broader policy landscape at /health/diseases/autism/.
Source note: This article includes information reported by CBS News.
